Real-time enrollment status for this lymphoma clinical trial
Current Status
Completed
Checked: March 2, 2026 at 8:48 AM UTC
| NCT Number | NCT05255601 |
| Recruiting Status | Completed |
| Condition | Lymphoma |
| Phase | Clinical Trial |
| Target Enrollment | 68 participants |
| Active Locations | 22 sites in the US |
| Sponsor | Bristol-Myers Squibb |
| Last Updated on CT.gov | February 25, 2026 (5 days ago) |
As of March 2, 2026: Clinical trial NCT05255601 is currently completed participants. This clinical trial study for lymphoma is not currently accepting new participants at 22 locations across the United States. The study is sponsored by Bristol-Myers Squibb. This status information is automatically verified from the official ClinicalTrials.gov registry.
No, NCT05255601 is currently completed. The study may resume recruiting in the future.
This trial is recruiting at 22 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05255601 was last updated 5 days ago (February 25, 2026). HelloStudys verifies this status automatically.